Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Press Releases

Latest Press Releases

XDR-TB patient Hanif, during his weekly consultation with Dr. Joan, at MSF’s clinic in Mumbai. Photograph by Atul Loke
Press release
Press release |
02 November 2022
Intellectual property and trade
United KingdomIndia

MSF responds to UK's disastrous proposal on intellectual property in UK-India Free Trade Agreement

3 min
MSF Counsellor, counselling parents of a six-year-old girl with drug-resistant TB at MSF independent Clinic, Mumbai- India Photograph by Atul Loke
Press release
Press release |
27 October 2022
Tuberculosis

MSF responds to WHO Global TB Report 2022, calls for scale up of shorter and safer DR-TB treatments to help save more lives

4 min
Haiti CTC Turgeau – MSF Health Promoter Jose verifies and keeps track on the health conditions of ill patients. Photograph by Alexandre Marcou
Press release
Press release |
19 October 2022
Tropical & neglected diseases

MSF responds to change in global cholera vaccine strategy amid unprecedented number of outbreaks

3 min
In South Kivu, MSF ran a mass immunization campaign in Fizi health zone that aims to vaccinate 120,000 children between the ages of 6 months and 15 years against measles over a period of six weeks. Photograph by Haavar Karlsen
Press release
Press release |
11 October 2022
Vaccines

MSF responds to WHO approval of South Africa’s vaccine regulatory system

3 min
GeneXpert test cartridge being used to test a sample of suspected TB in MSF’s lab at Bangassou Hospital, Central African Republic, 2017. Photo credit: Borja Ruiz Rodriguez/MSF
Press release
Press release |
14 September 2022
Diagnostics Tuberculosis

MSF warns that supply delays of critical TB test will cost lives

4 min
Juba, South Sudan. Cholera vaccination at the Protection of Civilians (PoC) site in Tomping. Photograph by MSF
Press release
Press release |
31 August 2022
Vaccines
Africa

MSF responds to agreement between Aspen Pharmacare and Serum Institute of India to produce four routine vaccines in South Africa

2 min
Herman gets tested for HIV in the PODI Ouest in Kinshasa, Democratic Republic of Congo. The PODIs, which are run by the RNOAC group of people with HIV, offer testing, support and Antiretroviral drugs (ARVs) to stable HIV patients in the capital. Photograph by Tommy Trenchard
Press release
Press release |
28 July 2022
HIV/AIDS

Following WHO recommendation, access to new game-changing HIV prevention drug needs to be accelerated

4 min
Jérôme Tognotti, MSF nurse supervisor, holding a vial of COVID vaccine used by teams to vaccinate homeless and migrant people Photograph by Nicolas Guyonnet
Press release
Press release |
24 June 2022
COVID-19

MSF responds to BioNTech announcement that it will set up first “BioNTainers” by end of 2022

3 min
  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury